Skip to Main Content

Latest Articles

“Utility of Cerebrospinal Fluid Unstimulated Interferon-Gamma (IRISA-TB) as a Same-Day Test for Tuberculous Meningitis in a Tuberculosis-Endemic, Resource-Poor Setting”
Tessa Adzemovic and others
Response to Letter to the Editor: Utility of Cerebrospinal Fluid Unstimulated Interferon-Gamma (IRISA-TB) as a Same-Day Test for Tuberculous Meningitis in a Tuberculosis-Endemic, Resource-Poor Setting
Philippa Randall and others
Clinical outcomes of hematopoietic cell transplantation and chimeric antigen receptor T-cell therapy in patients with antecedent Mycobacterium avium complex pulmonary disease: a case series of eight patients
Jessica Balbin and others
In this single-center case series, we identified eight patients with nontuberculous mycobacterial pulmonary disease (NTM-PD), all due to Mycobacterium avium complex, who underwent hematopoietic cell transplantation (HCT) or chimeric antigen receptor T-cell (CAR-T) therapy. None, including three without NTM-PD treatment ...
Virology Outcomes of Tenofovir-Lamivudine-Dolutegravir in Treatment-Naïve and Virologically Suppressed Individuals Switching From an Nnrti-Based Regimen: An Observational Analysis at 13 Sites
Cissy Kityo and others
Background Tenofovir/lamivudine/dolutegravir (TLD) is widely prescribed worldwide. We report virologic and resistance outcomes for patients initiating or switching to TLD. Methods A prospective observational study was performed at 13 AIDS Clinical Trials Group (ACTG) sites in six PEPFAR-supported countries coincident with ...
Minimal Impact of Prior Common Cold Coronavirus Exposure on Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination or Infection Risk in Older Adults in Congregate Care
Jessica A Breznik and others
Background Common cold coronaviruses were a frequent cause of respiratory infections in older adults living in congregate care homes before the coronavirus disease 2019 pandemic, which may influence immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and infection. We investigated ...

Editor's Choice

High Mortality and Associated Risk Factors in Kidney Transplant Recipients with Cryptococcosis – A Nationwide Cohort Study Over a Decade Using USRDS Data
Giuseppe Fiorica and others
Background Cryptococcosis is an invasive fungal disease that significantly contributes to morbidity and mortality among kidney transplant recipients (KTRs). Although various prognostic factors predictive of mortality have been identified, most research has been limited to single-center and ...
Candidemia in Left Ventricular Assist Device Recipients: Incidence, Risk Factors, and Outcomes
Rebecca Anderson and others
Background Candidemia (C-BSI) in LVAD recipients is poorly understood. This study aimed to investigate the incidence, risk factors and outcomes of C-BSI in LVAD recipients. Methods We screened 656 adults who underwent LVAD implantation at our institution from 1/1/2015 to 4/4/2024. Patients with ...
Aztreonam-avibactam demonstrates potent activity against carbapenem-resistant Enterobacterales collected from US medical centers over a six-year period (2017–2022)
Krisztina M Papp-Wallace and others
The activity of aztreonam-avibactam was evaluated against a contemporary collection of carbapenem-resistant Enterobacterales (CREs) from the US. Of the 511 CREs tested, 98.4% were susceptible to aztreonam-avibactam. The predominant underlying carbapenem-resistance mechanism identified was the presence of blaKPC.
Time to initiation of hepatitis B treatment is reduced with the use of the Xpert HBV viral load kit
Hailemichael Desalegn and others
The use of the Xpert HBV viral load kit reduced the turnaround time and provided faster treatment decisions in a real-life HBV program in Ethiopia. This strategy reduced patient loss and deaths in the lapse between enrolment and treatment initiation.

2024 Reviewer of the Year Recipients

The IDSA journals congratulate the 2024 Reviewer of the Year awardees for their excellence in completing peer reviews for IDSA’s three journals. OFID's 2024 recipients are Bruno A. Lopez-Luis, MD, MS, Eskild Petersen, and John Sellick Jr., DO, MS. Reviewers were selected through IDSA’s reviewer recognition and rewards program.

Learn more about the program

Sign up to become and IDSA peer reviewer

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close